Elekta AB (publ) (EKTA-B.ST)
- Previous Close
52.30 - Open
52.55 - Bid 52.60 x --
- Ask 52.65 x --
- Day's Range
52.30 - 53.45 - 52 Week Range
44.50 - 88.85 - Volume
816,958 - Avg. Volume
1,350,705 - Market Cap (intraday)
20.136B - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
19.38 - EPS (TTM)
2.72 - Earnings Date May 28, 2025
- Forward Dividend & Yield 2.40 (4.59%)
- Ex-Dividend Date Mar 6, 2025
- 1y Target Est
66.93
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
elekta.comRecent News: EKTA-B.ST
View MorePerformance Overview: EKTA-B.ST
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EKTA-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EKTA-B.ST
View MoreValuation Measures
Market Cap
20.14B
Enterprise Value
25.41B
Trailing P/E
19.38
Forward P/E
12.67
PEG Ratio (5yr expected)
1.30
Price/Sales (ttm)
1.13
Price/Book (mrq)
1.87
Enterprise Value/Revenue
1.42
Enterprise Value/EBITDA
8.81
Financial Highlights
Profitability and Income Statement
Profit Margin
5.80%
Return on Assets (ttm)
3.60%
Return on Equity (ttm)
9.82%
Revenue (ttm)
17.88B
Net Income Avi to Common (ttm)
1.04B
Diluted EPS (ttm)
2.72
Balance Sheet and Cash Flow
Total Cash (mrq)
3.58B
Total Debt/Equity (mrq)
81.83%
Levered Free Cash Flow (ttm)
804.37M